Abstract
Summary
A new anticonvulsant, 5,5-phenyl thienyl hydantoin, proposed for the treatment of epilepsy, has been compared with Dilantin and Mesantoin and Mesantoin by 4 different assay methods in rats and examined for its ability to modify the electroshock seizure pattern in man. The thienyl congener more closely resembles Dilantin than Mesantoin in its spectrum of antiepileptic actions.
Get full access to this article
View all access options for this article.